Form EFFECT BioLineRx Ltd.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 2, 2026 4:30 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioLineRx and Hemispherian present GLIX1 and PARP inhibitor data at ESMO
- X-Bow Selected by CoAspire to Provide Booster Motors for U.S. Navy CHAOS Program
- KROMATID Selected as Industry Resource Partnership Program Member by the California Institute for Regenerative Medicine (CIRM)
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share